Medical News

RSS

HRSA supports Sickle Cell Disease Treatment Demonstration Program with $1.6M award

HRSA has awarded $1.6 million to support the Sickle Cell Disease Treatment Demonstration Program (SCDTDP). The program is designed to establish practice models for the prevention and treatment of sickle cell disease through the coordinated efforts of providers, key stake holders, affected individuals and their families.

25 Oct 2010

O2h to provide ADME services to Sentinel Oncology under new extended contract

Executives from Sentinel Oncology Limited (Cambridge,UK) signed an agreement with O2h (Ahmedabad, India) to extend the number of FTEs working for Sentinel Oncology. Under this new contract, O2h will also provide ADME services to Sentinel Oncology.

25 Oct 2010

New synthetic population can help computational modelers to study infectious diseases

To help computational modelers who study the spread of infectious diseases, including flu, researchers supported by the National Institutes of Health at RTI International in North Carolina created a synthetic population mirroring U.S. demographics. Now they've added another layer of realism: where the virtual citizens live.

25 Oct 2010

Beijing CDC selects Sinovac as first priority supplier of seasonal influenza vaccine

Sinovac Biotech Ltd., a leading provider of biopharmaceutical products in China, announced today that it has been selected by the Beijing Centers for Disease Control and Prevention (Beijing CDC) as one of the five manufacturers to supply seasonal influenza vaccine to the citizens of Beijing.

25 Oct 2010

FlexBone shows potential replacement for current bone transplantations

With a failure rate as high as 50 percent, bone tissue grafts pose a significant obstacle to orthopedic surgeons attempting to repair complex fractures or large areas of bone loss, such as those often caused by trauma and cancer. Current synthetic substitutes rarely possess the bone-like properties needed for successful grafting and are often difficult for surgeons to manipulate in the operating room. In response to these challenges, researchers at UMass Medical School have developed an easy-to-produce, inexpensive, synthetic bone material called FlexBone.

25 Oct 2010

Gene therapy may reverse pulmonary hypertension

A Heart and Stroke Foundation researcher has discovered what could be the first truly effective breakthrough in the diagnosis and treatment of pulmonary hypertension, a devastating, life-threatening condition which results in an enlargement of the heart.

25 Oct 2010

Research Roundup: U.S. life expectancy ratings; Medicare Advantage outlook; Should advanced cancer patients have routine screening tests?

Health Affairs: What Changes In Survival Rates Tell Us About US Health Care -- Proponents of changes in the U.S. health system have often pointed to studies that find health outcomes in this country are worse than other developed nations, even though the United States "spends well over twice the median expenditure of industrialized nations on health care, and far more than any other country as a percentage of its gross domestic product." Others point to high rates of smoking, obesity and traffic fatalities.

25 Oct 2010

New gene therapy product reduces plasma cholesterol levels

Amsterdam Molecular Therapeutics (AMT) Holding N.V. a leader in the development of gene based therapies, today announced that its gene therapy product incorporating siRNA sequences into microRNA scaffolds to silence Apolipoprotein B100 (AAV-miApoB) was able to significantly lower plasma cholesterol levels in vivo over a period of 18 weeks. These preliminary results suggest that this approach could lead to a treatment for high cholesterol in humans

25 Oct 2010

$Precautions needed against cold-related frostbite, ankle sprains and fractures$

Precautions needed against cold-related frostbite, ankle sprains and fractures

With cold weather on the horizon, podiatrists at Temple University's School of Podiatric Medicine warn that people of all ages need to take precautions to protect their feet from cold-related injuries like frostbite, ankle sprains and fractures.

25 Oct 2010

Nestle announces plan to decrease sodium content in products

Nestle Prepared Foods Company today announced a comprehensive plan to decrease the sodium content in its products by another 10 percent from reductions made earlier this decade.

25 Oct 2010

Saint Francis HealthCare Partners and Phytel partner to achieve NCQA recognition

Saint Francis HealthCare Partners announced today that it has selected Phytel to help achieve NCQA recognition as a patient-centered medical home and will be rolling out Phytel's unique care coordination and population health management solution, Proactive Patient Outreach, in November.

25 Oct 2010

Experts identify efficient way to increase minority access to colorectal cancer screening

Minority patients have a significantly decreased survival from colon cancer compared to white patients, most often as a result of a late diagnosis. To help address this problem, a team of healthcare professionals at Memorial Sloan-Kettering Cancer Center has identified an efficient way to increase minority access to lifesaving colorectal cancer screening (CRCS) in communities where multiple barriers to preventive care exist.

25 Oct 2010

Sleep disturbances increase risk of work disability

Sleep disturbances increase the risk of work disability and may slow the return to work process. This is especially true in cases where work disability is due to mental disorders or musculoskeletal diseases. These results come from a recent study conducted by the Finnish Institute of Occupational Health in collaboration with the universities of Turku and London.

25 Oct 2010

Anxiety sensitivity levels may help in choosing medical treatment for AF patients

Levels of anxiety sensitivity may be important in choosing medical treatment for patients with heart failure and atrial fibrillation (AF), Montreal Heart Institute researchers today told the Canadian Cardiovascular Congress 2010, co-hosted by the Heart and Stroke Foundation and the Canadian Cardiovascular Society.

25 Oct 2010

Sen. Grassley asks HHS to probe doctors using excessive prescriptions

The Miami Herald: "Based on the huge numbers of prescriptions written by a Miami psychiatrist, Sen. Charles Grassley, R-Iowa, is continuing to pressure federal officials to investigate why some doctors write stunning numbers of scripts for tax-funded Medicare and Medicaid programs.

25 Oct 2010

Governor Rendell vetoes Senate Bill 1280

Governor Edward G. Rendell today vetoed Senate Bill 1280 noting the proposed legislation would destabilize the medical malpractice market, affecting physicians, other health care providers and ultimately the quality of care available.

25 Oct 2010

Research finds succimer drug not effective in removing mercury

Succimer, a drug used for treating lead poisoning, does not effectively remove mercury from the body, according to research supported by the National Institutes of Health. Some families have turned to succimer as an alternative therapy for treating autism.

25 Oct 2010

VTI expands into consumer electronics segment

VTI Technologies, a pioneer in Micro-Electro-Mechanical Systems (MEMS) for the past 20 years, is now taking a new direction and expanding into the consumer electronics segment. VTI is already the market leader in low-g sensors for the automotive industry, as well as in ultra-low power sensors for the medical implantable market.

25 Oct 2010

State officials adopt standards for insurers' expenses

The New York Times: "State insurance commissioners on Thursday unanimously endorsed tough new standards that would require many health insurance companies to spend more of each premium dollar for the benefit of consumers. The new federal health care law stipulates that at least 80 percent of premium revenue must be spent on medical care and 'activities that improve health care quality' for patients — not retained as profits or used to pay executive compensation and administrative expenses.

25 Oct 2010

Inovio announces publication of minimally-invasive intradermal device in journal Gene Therapy

Inovio Pharmaceuticals, Inc. a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today that a peer-reviewed research article describing the development of a new intradermal, minimally-invasive DNA vaccine delivery device was published in the prestigious journal Gene Therapy.

25 Oct 2010

Medical News

HRSA supports Sickle Cell Disease Treatment Demonstration Program with $1.6M award

O2h to provide ADME services to Sentinel Oncology under new extended contract

New synthetic population can help computational modelers to study infectious diseases

Beijing CDC selects Sinovac as first priority supplier of seasonal influenza vaccine

FlexBone shows potential replacement for current bone transplantations

Gene therapy may reverse pulmonary hypertension

Research Roundup: U.S. life expectancy ratings; Medicare Advantage outlook; Should advanced cancer patients have routine screening tests?

New gene therapy product reduces plasma cholesterol levels

Precautions needed against cold-related frostbite, ankle sprains and fractures

Nestle announces plan to decrease sodium content in products

Saint Francis HealthCare Partners and Phytel partner to achieve NCQA recognition

Experts identify efficient way to increase minority access to colorectal cancer screening

Sleep disturbances increase risk of work disability

Anxiety sensitivity levels may help in choosing medical treatment for AF patients

Sen. Grassley asks HHS to probe doctors using excessive prescriptions

Governor Rendell vetoes Senate Bill 1280

Research finds succimer drug not effective in removing mercury

VTI expands into consumer electronics segment

State officials adopt standards for insurers' expenses

Inovio announces publication of minimally-invasive intradermal device in journal Gene Therapy

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News